Isopto-Maxidex

Dexamethasone, the active ingredient in Isopto-Maxidex, is a corticosteroid presented as a 0.1% w/v ophthalmic suspension for ocular use. It treats post‑operative ocular inflammation, anterior uveitis, allergic conjunctivitis and other inflammatory eye conditions in patients requiring anti‑inflammatory therapy.

GNH USA supplies Isopto-Maxidex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Isopto-Maxidex, a corticosteroid ophthalmic suspension, is used to manage inflammatory eye conditions.

- Post‑operative ocular inflammation: reduces swelling, pain and redness after eye surgery. - Anterior uveitis: controls intra‑ocular inflammation and helps preserve vision. - Allergic conjunctivitis: alleviates itching, redness and watery discharge. - Other inflammatory eye conditions: provides anti‑inflammatory effect in various ocular disorders.

Ophthalmic dexamethasone may cause local and systemic adverse reactions.

Common Side Effects: - Transient eye irritation: mild burning or stinging on instillation. - Increased intra‑ocular pressure: mild rise detectable on routine exam. - Blurred vision: temporary visual disturbance after dosing. - Conjunctival hyperemia: mild redness of the eye.

Serious or Rare Side Effects: - Secondary ocular infection: risk of bacterial, fungal or viral infection due to immunosuppression. - Cataract formation: accelerated lens opacity with prolonged use. - Severe hypersensitivity: anaphylactic reaction or angioedema.

When using Isopto-Maxidex, consider the following precautions. - Monitor intra‑ocular pressure: regular eye pressure checks are recommended. - Use with caution in glaucoma patients: may exacerbate pressure elevation. - Avoid in active ocular infections: corticosteroid can worsen infection. - Limit duration of therapy: prolonged use increases risk of cataract and pressure rise. - Pregnancy and lactation: safety not established; prescribe only if benefit outweighs risk. - Store at room temperature: keep below 25°C, protect from moisture and light in original container.

Potential drug interactions should be reviewed before initiating therapy.

Major Interactions (Avoid): - Systemic corticosteroids: additive immunosuppression may increase infection risk. - CYP3A4 inhibitors (e.g., ketoconazole): may raise ocular dexamethasone levels.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may reduce tear production, enhancing irritation. - Non‑steroidal anti‑inflammatory eye drops: potential for reduced efficacy. - Antiviral agents (e.g., ganciclovir): monitor for delayed healing.